Tango Therapeutics, Inc. (TNGX)

NGM – Real Time Price. Currency in USD

26.21

-0.13 (-0.49%)

Market open: Aug 12, 2026, 1:09 PM EDT

26.23

-0.11 (-0.42%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

62M

42M

37M

25M

Cost of goods sold

-2M

-4M

Gross Profit

60M

40M

34M

21M

Operating expenses (excl. COGS)

-171M

-185M

-148M

-132M

Operating Income

-111M

-146M

-114M

-111M

Non-operating income, total

10M

16M

13M

Pretax income

-102M

-130M

-102M

-108M

Equity in earnings

Taxes

-4K

-208K

-134K

-54K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-102M

-130M

-102M

-108M

Discontinued operations

Net income

-102M

-130M

-102M

-108M

Dilution adjustment

Preferred dividends

Tango Therapeutics, Inc. (TNGX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tango Therapeutics, Inc. (TNGX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Tango Therapeutics, Inc. (TNGX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tango Therapeutics, Inc. (TNGX)

Income Statement (Annual)

Income Statement (Annual)